Psychedelic DMT studied for depression relief in early human trial
Symptom relief
Recruiting now
This Phase 1 study is testing the safety and brain effects of DMT, a psychedelic drug, in 60 adults with depression and healthy volunteers. Participants receive low or medium doses of DMT, THC, or a placebo, and researchers monitor mood, anxiety, and brain activity. The goal is t…
Phase: PHASE1 • Sponsor: Deepak C. D'Souza • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC